What question did this study set out to answer?

This review aims to highlight the role of cardiac MRI in diabetic cardiomyopathy.

December 8, 2025Cardiovascular DiabetologyOpen Access

Cardiac MRI in diabetic cardiomyopathy: translating imaging biomarkers into clinical practice

View Full Paper

Ask AI

Bookmark

Authors

Review shows imaging biomarkers improve risk stratification in diabetic cardiomyopathy, suggesting better treatment efficacy.

This review aims to highlight the role of cardiac MRI in diabetic cardiomyopathy.
Review of multiparametric cardiac magnetic resonance applications
Discussion of imaging biomarkers such as T1 mapping and late gadolinium enhancement
Analysis of emerging therapies including SGLT2 inhibitors and GLP-1 receptor agonists
Cardiac MRI identifies key features of diabetic cardiomyopathy such as microvascular dysfunction and steatosis.
Utilizing imaging biomarkers can stratify risk and monitor disease progression effectively.
Artificial intelligence integration can enhance automated analysis for early disease detection.

Huang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark